Clinical Trial Update: Study of AT-752 in Patients With Dengue Infection [Phase 2]

View source ↗

Summary

Phase 2 study of AT-752 in dengue infection was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• AT-752

Snippet

Sponsor: Atea Pharmaceuticals, Inc. | Conditions: Dengue Fever | Phase 2 | Status: TERMINATED | Results posted: 2024-03-05